CXC Receptor-2 Knockout Genotype Increases X-Linked Inhibitor of Apoptosis Protein and Protects Mice From Acetaminophen Hepatotoxicity

被引:42
作者
Hu, Bin [1 ]
Colletti, Lisa M. [1 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
关键词
NF-KAPPA-B; CELL-CYCLE ARREST; LIVER; ACTIVATION; JNK; CHEMOKINE; PATHWAYS; GROWTH; DEATH;
D O I
10.1002/hep.23715
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although acetaminophen is a commonly used analgesic, it can be highly hepatotoxic. This study seeks to further investigate the mechanisms involved in acetaminophen-induced hepatotoxicity and the role of chemokine (C-X-C motif) receptor 2 (CXCR2) receptor/ligand interactions in the liver's response to and recovery from acetaminophen toxicity. The CXC chemokines and their receptor, CXCR2, are important inflammatory mediators and are involved in the control of some types of cellular proliferation. CXCR2 knockout mice exposed to a median lethal dose of acetaminophen had a significantly lower mortality rate than wild-type mice. This difference was at least partially attributable to a significantly decreased rate of apoptosis in CXCR2 knockout mice versus wild-type mice; there were no differences seen in hepatocyte proliferation in wild-type mice versus knockout mice after this injury. Conclusion: The decreased rate of apoptosis in the knockout mice correlated with an almost undetectable and significantly decreased level of activated caspase-3 and significantly increased levels of X-linked inhibitor of apoptosis protein, which also correlated with increased levels of nuclear factor kappa B p52 and decreased levels of c-Jun N-terminal kinase; this provides a possible mechanism for the decrease in apoptosis seen in CXCR2 knockout mice. (HEPATOLOGY 2010;52:691-702)
引用
收藏
页码:691 / 702
页数:12
相关论文
共 22 条
[1]   IFN-γ-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes [J].
Bone-Larson, CL ;
Hogaboam, CM ;
Evanhoff, H ;
Strieter, RM ;
Kunkel, SL .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :7077-7083
[2]   NF-κB and JNK -: An intricate affair [J].
Bubici, C ;
Papa, S ;
Pham, CG ;
Zazzeroni, F ;
Franzoso, G .
CELL CYCLE, 2004, 3 (12) :1524-1529
[3]   Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties [J].
Caserta, TM ;
Smith, AN ;
Gultice, AD ;
Reedy, MA ;
Brown, TL .
APOPTOSIS, 2003, 8 (04) :345-352
[4]   Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control [J].
Chu, ZL ;
McKinsey, TA ;
Liu, L ;
Gentry, JJ ;
Malim, MH ;
Ballard, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10057-10062
[5]   N-ACETYL-PARA-BENZOQUINONE IMINE - A CYTOCHROME-P-450-MEDIATED OXIDATION-PRODUCT OF ACETAMINOPHEN [J].
DAHLIN, DC ;
MIWA, GT ;
LU, AYH ;
NELSON, SD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (05) :1327-1331
[6]   IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases [J].
Deveraux, QL ;
Roy, N ;
Stennicke, HR ;
Van Arsdale, T ;
Zhou, Q ;
Srinivasula, SM ;
Alnemri, ES ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1998, 17 (08) :2215-2223
[7]   c-jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity [J].
Gunawan, Basuki K. ;
Liu, Zhang-Xu ;
Han, Derick ;
Hanawa, Naoko ;
Gaarde, William A. ;
Kaplowitz, Neil .
GASTROENTEROLOGY, 2006, 131 (01) :165-178
[8]   Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury [J].
Hanawa, Naoko ;
Shinohara, Mie ;
Saberi, Behnam ;
Gaarde, William A. ;
Han, Derick ;
Kaplowitz, Neil .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (20) :13565-13577
[9]   Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines [J].
Hogaboam, CM ;
Bone-Larson, CL ;
Steinhauser, ML ;
Lukacs, NW ;
Colletti, LM ;
Simpson, KJ ;
Strieter, RM ;
Kunkel, SL .
FASEB JOURNAL, 1999, 13 (12) :1565-1574
[10]  
Ishida Y, 2006, EUR J IMMUNOL, V36, P1028, DOI 10.1002/eji.200535261